RITUXIMAB FOR INDUCTION OF REMISSION IN TYPE 1 AUTOIMMUNE PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Lanzillotta, M. [1 ]
Capurso, G. [2 ]
Wallace, Z. [3 ]
Karadag, O. [4 ]
Dagna, L.
Della Torre, E.
机构：
[1] Ist Sci San Raffaele, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy
[2] Ist Sci San Raffaele, PancreatoBiliary Endoscopy & EUS Div, Milan, Italy
[3] Massachusetts Gen Hosp, Clin Epidemiol Unit, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA
[4] Hacettepe Univ, Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.3993
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS1382
引用
收藏
页码：974 / 974
页数：1
相关论文
共 50 条
  • [21] THE CLINICAL EFFICACY OF AZATHIOPRINE AS MAINTENANCE TREATMENT FOR AUTOIMMUNE PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Masaki, Yoshiharu
    Nakase, Hiroshi
    Tsuji, Yoshihisa
    Nojima, Masanori
    Shimizu, Kyoko
    Mizuno, Nobumasa
    Ikeura, Tsukasa
    Uchida, Kazushige
    Ido, Akio
    Kodama, Yuzo
    Seno, Hiroshi
    Okazaki, Kazuichi
    Nakamura, Seiji
    Masamune, Atsushi
    GASTROENTEROLOGY, 2022, 162 (07) : S568 - S569
  • [22] The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis
    Yoshiharu Masaki
    Hiroshi Nakase
    Yoshihisa Tsuji
    Masanori Nojima
    Kyoko Shimizu
    Nobumasa Mizuno
    Tsukasa Ikeura
    Kazushige Uchida
    Akio Ido
    Yuzo Kodama
    Hiroshi Seno
    Kazuichi Okazaki
    Seiji Nakamura
    Atsushi Masamune
    Journal of Gastroenterology, 2021, 56 : 869 - 880
  • [23] Comparison of Efficacy and Safety of Mycophenolate Mofetil With Standard Therapy in Autoimmune Hepatitis for Induction and Maintenance of Remission: A Systematic Review and Meta-analysis
    Khan, Shahryar
    Ahmad, Aamer
    Khan, Mashal Alam
    Afridi, Rizwan
    Safwan, Qazi Muhammad
    Jadoon, Ahmed Khan
    Rehman, Zarlish
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1377 - S1378
  • [24] Adalimumab for induction of remission in patients with Crohn's disease: a systematic review and meta-analysis
    Juntao Yin
    Yang Li
    Yangyang Chen
    Chaoyang Wang
    Xiaoyong Song
    European Journal of Medical Research, 27
  • [25] Vedolizumab for induction of remission in Crohn's disease in adults, a systematic review and meta-analysis
    Lam, M. C. W.
    Fu, N.
    Bressler, B.
    Rosenfeld, G.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S227 - S228
  • [26] Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis
    Mosli, Mahmoud H.
    MacDonald, John K.
    Bickston, Stephen J.
    Behm, Brian W.
    Tsoulis, David J.
    Cheng, Jianfeng
    Khanna, Reena
    Feagan, Brian G.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (05) : 1151 - 1159
  • [27] Adalimumab for induction of remission in patients with Crohn's disease: a systematic review and meta-analysis
    Yin, Juntao
    Li, Yang
    Chen, Yangyang
    Wang, Chaoyang
    Song, Xiaoyong
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [28] Vedolizumab for Induction of Remission in Crohn's Disease in Adults, a Systematic Review and Meta-Analysis
    Lam, Mindy Ching Wan
    Fu, Nancy
    Rosenfeld, Greg
    Khanna, Reena
    Mosli, Mahmoud H.
    Bressler, Brian
    MacDonald, John K.
    Levesque, Barrett G.
    Feagan, Brian G.
    GASTROENTEROLOGY, 2015, 148 (04) : S271 - S272
  • [29] Prebiotics for Induction and Maintenance of Remission in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
    Limketkai, Berkeley N.
    Godoy-Brewer, Gala
    Shah, Neha D.
    Maas, Laura
    White, Jacob
    Parian, Alyssa M.
    Mullin, Gerard E.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [30] Rituximab for Rheumatoid Arthritis: A Meta-Analysis and Systematic Review
    Volkmann, Elizabeth R.
    Agrawal, Harsh
    Maranian, Paul
    Furst, Daniel E.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 749 - 760
12345